Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A unique role for cAMP signaling in microglia during opioid tolerance and withdrawal
    Published on 2023-07-28
    3 years ago
  • Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation
    Published on 2023-07-28
    3 years ago
  • Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
    Published on 2023-07-27
    3 years ago
  • Kynurenic acid: translational perspectives of a therapeutically targetable gliotransmitter
    Published on 2023-07-27
    3 years ago
  • Control of dopamine communication by opioids: glutamate enters the discussion
    Published on 2023-07-27
    3 years ago
  • Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study
    Published on 2023-07-25
    3 years ago
  • The orexin neurotransmitter system as a target for medication development for opioid use disorder
    Published on 2023-07-25
    3 years ago
« Previous 1 … 109 110 111 112 113 … 143 Next »
Journal of Psychopharmacology
  • Starting lithium in patients with compromised renal function – is it wise?
    Published on 2020-07-14
    6 years ago
  • Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studies
    Published on 2020-07-10
    6 years ago
  • Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents
    Published on 2020-07-10
    6 years ago
  • Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP
    Published on 2020-07-10
    6 years ago
  • The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder
    Published on 2020-07-10
    6 years ago
  • Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
    Published on 2020-07-10
    6 years ago
  • Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
    Published on 2020-07-10
    6 years ago
« Previous 1 … 109 110 111 112 113 … 145 Next »
European Neuropsychopharmacology
  • Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample
    Published on 2021-02-27
    5 years ago
  • P.313 Deep brain stimulation for refractory obsessive-compulsive disorder: a cohort of 70 cases with predictors of response
    Published on 2021-02-26
    5 years ago
  • P.314 Effect of a focused social and communication intervention (SCI) on preterm children at risk for ASD: a pilot study.
    Published on 2021-02-26
    5 years ago
  • P.315 Undetermined predominant polarity in bipolar disorder: time to refine an overlooked population
    Published on 2021-02-26
    5 years ago
  • P.316 The use of cannabidiol in treating psychiatric disorder: a systematic review
    Published on 2021-02-26
    5 years ago
  • P.317 Psychosis in Parkinson’s disease
    Published on 2021-02-26
    5 years ago
  • P.318 Neurobiological marker and intervention for socio-communicative impairments in autism spectrum disorders
    Published on 2021-02-26
    5 years ago
« Previous 1 … 109 110 111 112 113 … 166 Next »

   Pharma Pub